SLB
37
-4
MOS
48
-2
MHK
33
3
UA
51
-5
R
55
3
YUM
33
-2
FCX
40
5
XRAY
28
3
MAS
42
2
SYK
50
8
GRMN
52
6
AEE
63
5
LMT
29
7
SYF
71
-3
IRM
25
4
NEM
53
5
AAL
51
-3
THC
50
2
AEP
56
5
FLR
48
-4
SLB
37
-4
MOS
48
-2
MHK
33
3
UA
51
-5
R
55
3
YUM
33
-2
FCX
40
5
XRAY
28
3
MAS
42
2
SYK
50
8
GRMN
52
6
AEE
63
5
LMT
29
7
SYF
71
-3
IRM
25
4
NEM
53
5
AAL
51
-3
THC
50
2
AEP
56
5
FLR
48
-4
Financhill
Back

CrossFirst Bankshares Vs. Janux Therapeutics Industry Stock Comparison

Sell
47

CFB
CrossFirst Bankshares

Last Price:
$14.63
Seasonality Move:
-5.93%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
47
CrossFirst Bankshares (CFB) is a Sell

Is CrossFirst Bankshares a Buy, Sell or Hold?

  • The current CrossFirst Bankshares [CFB] share price is $14.64. The Score for CFB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • CFB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CFB Stock Price Chart

What is CrossFirst Bankshares's stock price today?

  • The CrossFirst Bankshares share price today is $14.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CFB is experiencing slight buying pressure.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

CFB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 25.32 Sell
Chaikin Money Flow: 88074 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 17.12) Sell
Bollinger Bands (100): (15.8 - 17.54) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

CFB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.97 Sell
20-day SMA: 15.79 Sell
50-day SMA: 16.56 Sell
200-day SMA: 15.38 Sell
8-day EMA: 15 Sell
20-day EMA: 15.62 Sell
50-day EMA: 16.21 Sell
200-day EMA: 15.51 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

CrossFirst Bankshares Earnings Growth & CFB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.14 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

CrossFirst Bankshares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):